GlassScriptPhysician profile
Joshua Armstrong
NPI 1225325343
$2,040.14
in general payments reported to CMS, 2019-2025
13 companies · $129 in 2025
The $129 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $94.76 · 2020: $77.07 · 2021: $134 · 2022: $343 · 2023: $1,207 · 2024: $55.20 · 2025: $129.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $956 · Food and Beverage: $436.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $955.57 |
| Food and Beverage | $435.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $1,163.10 | 2023 | Iovera |
| Zimmer Biomet Holdings, INC. | $190.24 | 2022-2025 | Gel-One Cross-Linked Hyaluronate |
| Medtronic, INC. | $186.53 | 2022 | |
| Horizon Therapeutics Plc | $131.42 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $114.08 | 2019-2023 | Euflexxa |
| Si-Bone, INC. | $52.88 | 2021-2022 | |
| Boston Scientific Corporation | $47.57 | 2021-2022 | |
| Depuy Synthes Sales INC. | $34.29 | 2019-2021 | |
| Spr Therapeutics, INC | $28.30 | 2024 | Sprint Pns System |
| Bioventus LLC | $26.90 | 2024 | Durolane |
| Mdd US Operations, LLC | $25.64 | 2020 | |
| Pfizer INC. | $25.00 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $14.19 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Armstrong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.